AI summary by TwinMind

The Chinese Hamster Revolutionized Medicine

Asianometry

20m 12s

World's Top-Selling Drugs and Antibody Dominance

  • 2023 top-selling drug: Keytruda (antibody) - $25 billion sales, $27 billion projected 2024
  • 5 of top 10 bestselling drugs in 2023 were antibodies
  • Antibody therapies revolutionized medicine but manufacturing remained challenge

Antibody Fundamentals and Early History

  • Antibodies: Y-shaped proteins that bind foreign bodies, signal white blood cells for destruction
  • Also called immunoglobulins, produced by B lymphocytes/B cells from bone marrow
  • Named by Nobel winner Paul Ehrlich (1897) - originally "anti-körper" placeholder term
  • Early serum therapy method: inoculate animals (horses), harvest serum, purify for treatment
    • Emil von Behring won 1901 Nobel for diphtheria antitoxin (saved 50,000 children/year)
    • Problems: unreliable activity, serum sickness, contamination risks
    • 1901 tetanus contamination killed dozen children
  • Linus Pauling attempted artificial antibodies (1940s) but couldn't replicate results

Monoclonal Antibody Breakthrough

  • Monoclonal = exact copies of single antibody (single clones)
  • 1960s research on myelomas (plasma cell cancers) - infinite reproduction, faulty antibody production
  • Cesar Milstein & George Köhler breakthrough using Sendai virus
    • Fused mouse myeloma cells with mouse B cells creating hybridomas
    • Combined cancer cell longevity with B cell antibody production
    • Worked on first try, won 1984 Nobel Prize
    • Milstein never patented method (miscommunication or didn't see commercial potential)

Early Commercial Challenges

  • 1980 press called monoclonal antibodies "Magic Bullets" - set unrealistic expectations
  • First treatment approved 1986: Muromonab-CD3 (OKT3) for kidney transplant rejection
  • Major problems with mouse-derived antibodies:
    • 5-10% patients suffered complications, some severe allergic shock
    • Genetically unstable hybridomas
    • Short-lived in human body, required large frequent doses
    • Human immune system didn't recognize mouse antibodies
  • 1980s London: millions invested in startups, most failed
  • 15 years after 1975 Nobel discovery yielded only one US approved treatment
  • Industry exec: "molecular snake oil"

Chinese Hamster Laboratory History

  • Chinese hamster: small rodent from northern China/Mongolia, grayish-brown, large scrotum
  • 1919: Dr. E.T. Tseh (Peking Union Medical College) first used for pneumococcus research
  • Considered agricultural pest but vulnerable to human diseases
  • Problem: wouldn't breed in captivity, solitary and aggressive
  • Late 1920s Harvard failed to breed 150 hamsters despite building basement burrows

The Great Hamster Escape (1948)

  • Chinese Civil War threatened hamster supply
  • December 6, 1948: Dr. H.C. Chou sent 20 hamsters (10 male, 10 female) to Dr. Robert Watson
  • Watson fled Nanjing as Communist forces approached across Yangtze River
  • 5:45 AM escape in ice-cold rain with brandy, prayers, Colt .45
  • 11-hour drive to Shanghai avoiding mudslides and Communist troops
  • Took last Pan Am flight to US
  • April 1949: People's Liberation Army conquered Nanjing, People's Republic declared
  • Watson brought hamsters to Victor Schwentker (rodent breeder, New York)
  • Communist Party later condemned Watson to death for alleged germ warfare
  • Dr. Chou convicted, sent to re-education camp, committed suicide with wife 1966

CHO Cell Line Development

  • Schwentker successfully bred hamster colony
  • 1954: George Yerganian discovered low chromosome count ideal for genetic research
  • Random genetic quirk created diabetic hamster lineage useful for diabetes research
  • 1957: Theodore Puck (University of Colorado) developed immortal cell lines
  • Extracted cells from single female hamster ovary, cultivated 10+ months
  • Created famous Chinese Hamster Ovary (CHO) K1 line
  • 1960s-1970s: CHO cells known for big chromosomes, hardy cultures, identifiable mutations

Genentech and Protein Production Revolution

  • 1976: Roberts Swanson (VC) and Herbert Boyer (UCSF biochemist) founded Genentech
  • Boyer pioneered recombinant DNA techniques
  • Successfully used E. coli for human insulin and growth hormone
  • E. coli failed for complex proteins like TPA (blood clot enzyme) and hepatitis B vaccine
  • Problem: E. coli couldn't perform glycosylation (sugar attachment for protein folding)
  • Needed more sophisticated "biofactory" for complex proteins

DHFR Gene Amplification System

  • 1976: Stanford student Fred Alt discovered CHO cell trick with methotrexate
  • Methotrexate kills cancer cells by blocking DHFR enzyme
  • Cells develop resistance by rapidly amplifying DHFR gene
  • Process: Delete DHFR genes from CHO K1 cells, introduce desired protein gene linked to DHFR
  • Cells rapidly uptake and amplify both genes to survive methotrexate treatment
  • Result: CHO cells mass-producing desired proteins

Commercial Success and Humanization

  • 1987: Genentech set up 10,000L vats of CHO cells producing TPA at scale
  • Final step: humanize antibodies by reducing non-human sequences
  • H-score developed for judging sequence humanness
  • 1997: Genentech/IDEC launched Rituximab for autoimmune disease and cancer
  • 1998: FDA approved Trastuzumab (Herceptin) for aggressive breast cancer
    • Revolutionized treatment of former death sentence
    • Advocates forced FDA fast-tracking due to successful early trials
    • Remains gold standard for HER2+ breast cancer
  • Both produced in South San Francisco facility using CHO cells
  • 2023: Legacy production center closed, 265 layoffs

Current Dominance and Future

  • CHO platform dominates antibody/recombinant protein mass production
  • 2014-2018: 71 new pharmaceuticals introduced, 80%+ manufactured by CHO cells
  • E. coli distant second choice
  • FDA familiarity reduces regulatory uncertainty
  • 30 years fine-tuning: high yields, growth rates
  • Production costs fell from $110,000/gram to ~$100/gram
  • Biotech VCs won't back monoclonal antibody therapies made outside CHO platform

Manufacturing Challenges and Future Prospects

  • Gene therapies like Lentmeldi cost $4.5 million/dose due to lack of scalable manufacturing
  • Each gene therapy essentially custom-made like Lamborghini
  • Antibody-drug conjugates emerging: "laser-guided chemotherapy"
  • Use specific antibodies to deliver warheads directly to cancer cells
  • Antibodies haven't reached peak potential despite dominating top 10 drugs

TwinMind

Get summaries like this for your own meetings

TwinMind takes notes in the background during meetings, lectures, and calls, then writes the summary for you.

Free plan to get started

No bot joins your calls

Phone, desktop & Chrome apps

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome